Question

Will oral semaglutide be approved for the treatment of obesity by the FDA or EMA by 2027?

1 comment1

Total Forecasters45

Community Prediction

76%

(74% - 81%)

Make a Prediction

50%

community: 76%

No key factors yetAdd some that might influence this forecast.

Add key factor

Authors:

casens

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Spot Scoring Time:

Nov 26, 2021

Health & Pandemics

Scientists discover a way for the body to produce 'natural Ozempic' without the nasty side effects

Daily Mail•Jul 10, 2025

Lizzo Breaks Silence on Ozempic: A Deep Dive into Her Transformation

•Jul 10, 2025

Saxenda Weight Loss Results: Lose Up to 10% Body Weight Safely

•Jul 10, 2025

Learn more about Metaculus NewsMatch

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

63%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

45%

Authors:

casens

Opened:

Nov 24, 2021

Closes:

Dec 31, 2026

Scheduled resolution:

Jan 1, 2027

Spot Scoring Time:

Nov 26, 2021

Health & Pandemics

Scientists discover a way for the body to produce 'natural Ozempic' without the nasty side effects

Daily Mail•Jul 10, 2025

Lizzo Breaks Silence on Ozempic: A Deep Dive into Her Transformation

•Jul 10, 2025

Saxenda Weight Loss Results: Lose Up to 10% Body Weight Safely

•Jul 10, 2025

Learn more about Metaculus NewsMatch

Will the FDA or EMA withdraw approval of Semaglutide for the treatment of obesity by 2027?

Will a small molecule GLP-1-based drug be approved for the treatment of obesity by the FDA or EMA by 2029?

63%

Will the combination of semaglutide and cagrilintide be approved for the treatment of obesity by the FDA or EMA by 2027?

45%